AbbVie Inc. (TSX:ABBV)
Canada flag Canada · Delayed Price · Currency is CAD
29.25
-1.57 (-5.09%)
At close: Mar 18, 2026

AbbVie Ratios and Metrics

Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
504,412554,713430,739375,788392,608328,778
Market Cap Growth
-5.24%28.78%14.62%-4.28%19.41%26.59%
Enterprise Value
590,929631,918506,020429,910461,183403,479
PE Ratio
87.8896.8274.3556.9724.3820.99
Forward PE
14.2916.5714.8113.9612.7210.04
PEG Ratio
-1.091.6858.43-2.03
PS Ratio
6.026.615.575.044.934.26
PB Ratio
-113.97-123.5494.3426.4216.5715.54
P/TBV Ratio
-15.86-123.8994.7626.5216.6515.62
P/FCF Ratio
20.6522.6717.5912.4011.7910.89
P/OCF Ratio
19.3321.2316.6811.9811.4610.51
EV/Sales Ratio
7.067.526.545.765.795.23
EV/EBITDA Ratio
14.5619.8221.0314.5912.6311.11
EV/EBIT Ratio
20.4430.5340.3324.5418.5416.39
EV/FCF Ratio
24.1925.8320.6714.1913.8513.36
Debt / Equity Ratio
-19.03-19.0317.945.023.424.16
Debt / EBITDA Ratio
2.912.913.832.772.382.90
Debt / FCF Ratio
3.793.793.772.692.613.49
Net Debt / Equity Ratio
-19.03-19.0318.524.503.134.34
Net Debt / EBITDA Ratio
2.682.683.522.172.032.53
Net Debt / FCF Ratio
3.493.493.452.112.233.04
Asset Turnover
0.450.450.420.400.410.38
Inventory Turnover
3.993.994.085.325.195.42
Quick Ratio
0.410.410.430.630.690.56
Current Ratio
0.670.670.660.870.960.79
Return on Equity (ROE)
6225.00%6225.00%62.29%35.20%72.40%80.95%
Return on Assets (ROA)
7.19%7.19%7.81%7.27%11.16%10.73%
Return on Invested Capital (ROIC)
10.10%10.10%11.16%10.18%14.60%13.51%
Return on Capital Employed (ROCE)
16.12%16.12%9.45%12.38%16.43%15.37%
Earnings Yield
1.14%1.03%1.34%1.76%4.10%4.76%
FCF Yield
4.84%4.41%5.68%8.06%8.48%9.18%
Dividend Yield
4.04%2.88%3.51%3.85%3.51%3.86%
Payout Ratio
36.56%275.84%257.71%216.72%84.85%80.24%
Buyback Yield / Dilution
0.20%0.20%0.48%0.65%0.43%0.29%
Total Shareholder Return
4.25%3.08%3.98%4.50%3.94%4.15%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.